Table 2.

DEGs and the respective biological process in DF-1 cells upon ARV infection. DEGs with fold change > 2 are listed

	Gene-id	Gene-name	Description	Keywords of biological process	Fold change
					10 hpi	18 hpi
Up	ENSGALG00000016400	RSAD2	Radical S-adenosyl methionine domain containing 2	antiviral defense, innate immunity, et al.	6.9368	3.2553
	ENSGALG00000006384	IFIT5	Interferon induced protein with tetratricopeptide repeats 5	antiviral defense, innate immunity, et al.	6.7163	3.3529
	ENSGALG00000013723	OASL	2′-5′-oligoadenylate synthetase-like	antiviral defense, innate immunity, et al.	6.2188	3.2579
	ENSGALG00000013575	ISG12(2)	Interferon-stimulated genes 12 (2)	–	6.0596	2.2561
	ENSGALG00000016142	Mx	Myxovirus resistance	antiviral defense, innate immunity, et al.	5.5442	2.653
	ENSGALG00000028982	CMPK2	Cytidine monophosphate (UMP-CMP) kinase 2	Pyrimidine biosynthesis	4.1368	2.3091
	ENSGALG00000009479	SAMD9L	Sterile alpha motif domain containing protein 9-like	endosomal vesicle fusion	3.5798	2.8676
	ENSGALG00000006138	HELZ2	Helicase with zinc finger domain 2	Transcription regulation	2.9797	2.4167
	ENSGALG00000016964	EPSTI1	Epithelial stromal interaction 1	–	2.2115	1.7528
	Novel00328	predicted: TRIM25-like	Tripartite motif containing 25	antiviral defense, innate immunity, et al.	2.1606	–
	Novel00773	predicted: EEA1-like	Early endosome antigen 1-like	endocytosis, vesicle fusion, et al.	2.1431	–
Down	ENSGALG00000010791	LEXM	Lymphocyte expansion molecule	positive regulation of cell proliferation, et al.	−5.4359	–
	ENSGALG00000000607	GPR37L1	G protein-coupled receptor 37 like 1	positive regulation of MAPK cascade, et al.	−5.2343	–
	ENSGALG00000002742	TMEM132B	Transmembrane protein 132B	–	−2.6179	–
	Novel01111	lncRNA	Uncharacterized LOC107053801	–	−2.4302	–